Stock Scorecard
Stock Summary for Opko Health Inc (OPK) - $1.26 as of 4/26/2024 9:36:38 PM EST
Total Score
12 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for OPK
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for OPK
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for OPK
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 |
Bonus Criteria for OPK
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for OPK
Financial Details for OPK
Company Overview |
|
---|---|
Ticker | OPK |
Company Name | Opko Health Inc |
Country | USA |
Description | OPKO Health, Inc., a healthcare company, is engaged in the pharmaceutical and diagnostic businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company is headquartered in Miami, Florida. |
Sector Name | LIFE SCIENCES |
Industry Name | PHARMACEUTICAL PREPARATIONS |
Most Recent Quarter | 12/31/2023 |
Next Earnings Date | 5/1/2024 |
Stock Price History |
|
Last Day Price | 1.26 |
Last Day Price Updated | 4/26/2024 9:36:38 PM EST |
Last Day Volume | 1,945,283 |
Average Daily Volume | 10,189,667 |
52-Week High | 2.24 |
52-Week Low | 0.85 |
Last Price to 52 Week Low | 48.24% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 101.20 |
Sector PE | 61.73 |
5-Year Average PE | -18.04 |
Free Cash Flow Ratio | 9.00 |
Industry Free Cash Flow Ratio | 12.66 |
Sector Free Cash Flow Ratio | 30.74 |
Current Ratio Most Recent Quarter | 1.55 |
Total Cash Per Share | 0.14 |
Book Value Per Share Most Recent Quarter | 1.80 |
Price to Book Ratio | 0.62 |
Industry Price to Book Ratio | 5.66 |
Sector Price to Book Ratio | 22.08 |
Price to Sales Ratio Twelve Trailing Months | 0.99 |
Industry Price to Sales Ratio Twelve Trailing Months | 5.48 |
Sector Price to Sales Ratio Twelve Trailing Months | 5.16 |
Share Statistics |
|
Total Shares Outstanding | 696,992,000 |
Market Capitalization | 878,209,920 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Last Dividend Amount | 0.00 |
Current Dividend Amount | 0.00 |
Dividend Aristocrat? | False |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 3.93% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 19.10% |
Annual Earnings Growth | 42.49% |
Reported EPS 12 Trailing Months | -0.25 |
Reported EPS Past Year | 0.00 |
Reported EPS Prior Year | -0.25 |
Net Income Twelve Trailing Months | -188,863,000 |
Net Income Past Year | -188,863,000 |
Net Income Prior Year | -328,405,000 |
Quarterly Revenue Growth YOY | -1.90% |
5-Year Revenue Growth | -3.15% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 95,881,000 |
Total Cash Past Year | 95,881,000 |
Total Cash Prior Year | 153,839,000 |
Net Cash Position Most Recent Quarter | -153,464,000 |
Net Cash Position Past Year | -153,464,000 |
Long Term Debt Past Year | 249,345,000 |
Long Term Debt Prior Year | 256,251,000 |
Total Debt Most Recent Quarter | 249,345,000 |
Equity to Debt Ratio Past Year | 0.85 |
Equity to Debt Ratio Most Recent Quarter | 0.85 |
Total Stockholder Equity Past Year | 1,389,219,000 |
Total Stockholder Equity Prior Year | 1,561,648,000 |
Total Stockholder Equity Most Recent Quarter | 1,389,219,000 |
Options |
|
Put/Call Ratio | 0.69 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | 0.04 |
MACD Signal | 0.06 |
20-Day Bollinger Lower Band | 0.69 |
20-Day Bollinger Middle Band | 1.13 |
20-Day Bollinger Upper Band | 1.56 |
Beta | 1.84 |
RSI | 50.86 |
50-Day SMA | 1.44 |
200-Day SMA | 2.80 |
System |
|
Modified | 4/25/2024 8:08:26 AM EST |